Lawyers for US cancer sufferers challenge Bayer’s $7.25bn Roundup settlement deal
AI Summary
A group of 14 law firms representing nearly 20,000 plaintiffs is challenging Bayer's proposed $7.25 billion Roundup settlement deal in St. Louis, Missouri. The firms filed motions to intervene and extend the court's preliminary approval timeline, citing concerns that the settlement is unfair to cancer sufferers. They argue the deal disproportionately favors Bayer and provides inadequate compensation to many class members in exchange for surrendering their rights. Specifically, the firms object to the payment schedule, which they say favors occupational users of Roundup over residential users. Bayer, facing over 100,000 lawsuits since acquiring Monsanto, maintains its glyphosate herbicides do not cause cancer, despite previous settlements and verdicts. The opposing law firms seek broader public scrutiny of the proposed settlement due to its scale and potential impact.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories